Cefuroxime Axetil + Clavulanic Acid
Brand Formulations & Prices
176 brands sorted by unit price
Clacef
Fuclav
Cefaclav
Clavusef
Furotil Plus
Cerox CV
Furoget CV
Relacef Plus
Ceclav
Cefuson Plus
Claviator-CV
Clavimax-CV
Cosmotil
Eurix CV
Meroclav
Neoclav
Probac Plus
Rapiclav
Roximax Plus
Staxiclav
Clavuxet
Recofast CV
Sharpkil Plus
Cefurim CV
Clavuxim
Clavucure
Doctil Plus
Fuxtil CV
Cefurav Plus
Fixcef Plus
Ximeclav
Axeclav
Axim CV
Brocef CV
Cefaclav
Cefotil Plus
Cefusil CV
Cefuxet Plus
Ceroclav
Cerox CV
Clacef
Clavurox
Clavusef
Clavutil
Co-Axet
Famiclav
Fuclav
Furoclav
Furotil Plus
Kefuclav
Mexclav
Nucef CV
Roclav
Roxibac Plus
Roxiclav
Turboclav
Xiclav
Xinarox CV
Zinaclav
Cefuxim-CV
Axicef Plus
Benkill CV
Roxilab Plus
Secoclav
Zerotil Plus
Furoget CV
Relacef Plus
Ceclav
Cefurino Plus
Cefuson Plus
Claviator-CV
Clavimax-CV
Cosmotil
Eurix CV
Meroclav
Neoclav
Probac Plus
Rapiclav
Roximax Plus
Staxiclav
Adrox CV
Cefurav Plus
Cefurim CV
Clacef
Clavucure
Clavutil
Clavuxim
Co-Axet
Fixcef Plus
Furonaaf-CV
Fuxtil CV
Recofast CV
Rofuclav
Roxiclav
Roxtal XP
Sharpkil Plus
Xinarox CV
Fuclav
Ximeclav
Doctil Plus
Athexim CV
Benkill CV
Brocef CV
Cefaclav
Cefotil Plus
Cefuroxime Plus
Cefusil CV
Cefuxet Plus
Ceroclav
Cerox CV
Clavurox
Clavusef
Famiclav
Furoclav
Furotil Plus
Kefuclav
Mexclav
Nucef CV
Roclav
Roxilab Plus
Starclav
Turboclav
Xiclav
Axeclav
Axicef Plus
Axim CV
Roxibac Plus
Secoclav
Zinaclav
Cefuxim-CV
Zerotil Plus
Roxtal XP
Adrox CV
Furonaaf-CV
Rofuclav
Axeclav
Ceclav
Cefurav Plus
Cefurino Plus
Ceroclav
Claviator-CV
Clavuxim
Co-Axet
Eurix CV
Furoget CV
Fuxtil CV
Meroclav
Rapiclav
Roclav
Xiclav
Mexclav
Cefurim CV
Fuclav
Cefaclav
Clacef
Clavucure
Clavusef
Famiclav
Furoclav
Sharpkil Plus
Turboclav
Ximeclav
Doctil Plus
Furotil Plus
Axicef Plus
Adrox CV
Axim CV
Cefotil Plus
Cerox CV
Clavurox
Clavutil
Furonaaf-CV
Kefuclav
Roxilab Plus
Zerotil plus
Rofuclav
📖 Official Clinical Monograph
DGDA Approved Prescribing GuidelinesAdrox CV is indicated for the treatment of infections caused by sensitive bacteria.
Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.
Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.
... Read more
Adrox CV is indicated for the treatment of infections caused by sensitive bacteria.
Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.
Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains) or Streptococcus pyogenes.
Acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae or Haemophilus influenzae (non beta-lactamase producing strains)
Lower respiratory tract infections including pneumoniae, caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase-producing strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, E. coli.
Acute bacterial exacerbation of chronic bronchitis and secondary bacterial infections of Acute bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (beta-lactamase negative strains) or Haemophilus parainfluenzae (beta-lactamase negative strains).
Uncomplicated skin and skin-structure infections caused by Staphylococcus aureus (including beta-lactamase producing strains) or Streptococcus pyogenes.
Uncomplicated urinary tract infections caused by E.coli or Klebsiella pneumoniae.
Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains).
Uncomplicated Gonorrhoea caused by penicillinase-producing and non-penicillinase producing strains of Neisseria gonorrhoeae.
Early Lyme Disease (erythema migrans) caused by Borrelia burgdorferi.
Septicemia caused by Staphylococcus aureus, Streptococcus pneumoniae, E.coli, Haemophilus influenzae (including ampicillin-resistant strains) & Klebsiella spp.
Meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin-resistant strains), Neisseria meningitidis & Staphylococcus aureus (penicillinase and non-penicillinase producing strains)
Switch therapy (Injectable to oral)
Adolescents and adults (13 years and older)-
Pharyngitis/tonsillitis
: 250 mg b.i.d. for 5-10 days
Acute bacterial maxillary sinusitis
: 250 mg b.i.d. for 10 days
Acute bacterial exacerbation of chronic bronchitis
: 250-500 mg b.i.d. for 10 days
Secondary bacterial infections of acute bronchitis
: 250-500 mg b.i.d. for 5-10 days
Uncomplicated skin and skin structure infections
: 250-500 mg b.i.d. for 10 days
Uncomplicated urinary tract infections
: 250 mg b.i.d. for 7-10 days
Uncomplicated Gonorrhoea
: 1000 mg b.i.d. Single dose
Community acquired pneumonia
: 250-500 mg b.i.d. for 5-10 days
MDR Typhoid Fever
: 500 mg b.i.d. for 10-14 days
Early Lyme disease
: 500 mg b.i.d. for 20 days
Paediatric Patients (3 months to 12 years)-
Pharyngitis/Tonsillitis
: 20 mg/kg/day b.i.d for 5-10 days
Acute otitis media
: 30 mg/kg/day b.i.d for 10 days
Acute bacterial maxillary sinusitis
: 30 mg/kg/day b.i.d for 10 days
Impetigo
: 30 mg/kg/day b.i.d for 10 days
Cefuroxime-Clavulanic Acid tablet may be taken without regard of food.
Cefuroxime-Clavulanic Acid is contraindicated in patients with known allergy to cephalosporin & in patients with Pseudomembranous Colitis.
Generally Cefuroxime-Clavulanic Acid is well tolerated. However, a few side effects like nausea, vomiting, diarrhea, abdominal discomfort or pain may occur. As with other broad-spectrum antibiotics, prolonged administration of Cefuroxime and Clavulanic acid combination may result in overgrowth of nonsusceptible microorganisms. Rarely (<0.2%) renal dysfunction, anaphylaxis, angioedema, pruritis, rash and serum sickness like urticaria may appear.
Cefuroxime should be given with care to patients receiving concurrent treatment with potent diuretics & who has history of colitis.
Cefuroxime is a bactericidal second generation cephalosporin antibiotic which is active against a wide range of Gram-positive and Gram-negative susceptible organisms including many beta-lactamase producing strains. Cefuroxime inhibits bacterial cell wall synthesis by interfering with the transpeptidation process.
Clavulanic acid is a naturally derived beta lactamase inhibitor produced by Streptomyces clavuligerus. It has similar structure to beta lactam antibiotics which binds irreversibly to beta-lactamase enzymes and inactivates them. Clavulanic acid gives protection of Cefuroxime from degradation by beta lactamase enzymes and provides a solution for the treatment of bacterial infections caused by beta lactam resistant bacteria.